Edit
Bizwit-Logo-Final

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Global neurological biomarkers market to reach USD 13.42 billion in 2027

Global Neurological Biomarkers Market Size study, by Application (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Autism Spectrum Disorder, and Others), by Type (Genomic, Proteomic, Metabolomic, Imaging, and Others), by End-use (Hospital & Hospital Laboratories, Independent Clinical Diagnostic Centers, and Research Organizations and Others), and Regional Forecasts 2021-2027

Product Code: HALB_36383612
Publish Date: 27-12-2021
Page: 200

Global neurological biomarkers market is valued approximately at USD 6.19 billion in 2020 and is anticipated to grow with a healthy growth rate of about 12.14% over the forecast period 2021-2027. Neurological biomarkers are increasingly gaining popularity among the healthcare professionals across the globe for tracking the health of the brain. This assists in early detection of a disease, less invasive diagnostics while enabling faster drug development. Rising adoption of personalized medicine, rising prevalence of neurological disorders, and increasing strategic developments by market players and government support are some of the factors that are expected to significantly contribute towards the growth of global neurological biomarkers market during the forecast period. According to the Alzheimer’s Disease International, the total number of people experiencing dementia across the globe is expected to increase from 36 million people in 2010, to 66 million people by 2030 and further to 115 million people by 2050. Such growth is expected to increase the demand and adoption of biomarkers for rapid detection as well as evaluation of patients experiencing neurological diseases, hence promoting the market growth. In addition, technological innovations provide lucrative growth opportunities to the market. However, lengthy timelines for biomarker development and lack of reimbursement coverage are expected to hamper the growth of global neurological biomarkers market during the forecast years.

The regional analysis of the global neurological biomarkers market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America accounts for the largest share in terms of market revenue in the global neurological biomarkers market over the forecast period 2021-2027. Factors such as high disease burden, availability of a range of products for clinical use, acceptance of biomarkers for drug development, diagnostic, prognostic purposes, etc. contribute towards the largest market share of the region in the forecast years. However, Asia Pacific is expected to emerge as the fastest growing region owing to factors such as rising disease burden, rise in the number of clinical trials etc.
Major market player included in this report are:
Abbott Laboratories
Bio-Rad Laboratories, Inc
Thermo Fisher Scientific Inc
F. Hoffman-La Roche Ltd
Johnson and Johnson services inc
Rules Based Medicine – a Q2 Solutions Company
Quanterix
ADx Neurosciences
Banyan Biomarker, Inc.
Abcam Plc
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Application:
Alzheimer’s Disease
Parkinson’s Disease
Multiple Sclerosis
Autism Spectrum Disorder
Others
By Type:
Genomic
Proteomic
Metabolomic
Imaging
Others
By End-use:
Hospital & Hospital Laboratories
Independent Clinical Diagnostic Centers
Research Organizations and Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027.

Target Audience of the Global Neurological Biomarkers Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Neurological Biomarkers Market, by Region, 2019-2027 (USD Billion)
1.2.2. Neurological Biomarkers Market, by Application, 2019-2027 (USD Billion)
1.2.3. Neurological Biomarkers Market, by Type, 2019-2027 (USD Billion)
1.2.4. Neurological Biomarkers Market, by End-use, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Neurological Biomarkers Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Neurological Biomarkers Market Dynamics
3.1. Neurological Biomarkers Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Rising adoption of personalized medicine
3.1.1.2. Rising prevalence of neurological disorders
3.1.1.3. Increasing strategic developments by market players and government support
3.1.2. Market Challenge
3.1.2.1. Lack of reimbursement coverage
3.1.2.2. Lengthy timelines for biomarker development
3.1.3. Market Opportunities
3.1.3.1. Technological innovations
Chapter 4. Global Neurological Biomarkers Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Top Investment Opportunities
4.5. Top Winning Strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk assessment: COVID -19 Impact
5.1. Assessment of the Overall Impact of COVID-19 on the industry
5.2. Pre COVID-19 and Post COVID-19 Market Scenario
Chapter 6. Global Neurological Biomarkers Market, by Application
6.1. Market Snapshot
6.2. Global Neurological Biomarkers Market by Application, Performance – Potential Analysis
6.3. Global Neurological Biomarkers Market Estimates & Forecasts by Application 2018-2027 (USD Billion)
6.4. Neurological Biomarkers Market, Sub Segment Analysis
6.4.1. Alzheimer’s Disease
6.4.2. Parkinson’s Disease
6.4.3. Multiple Sclerosis
6.4.4. Autism Spectrum Disorder
6.4.5. Others
Chapter 7. Global Neurological Biomarkers Market, by Type
7.1. Market Snapshot
7.2. Global Neurological Biomarkers Market by Type, Performance – Potential Analysis
7.3. Global Neurological Biomarkers Market Estimates & Forecasts by Type 2018-2027 (USD Billion)
7.4. Neurological Biomarkers Market, Sub Segment Analysis
7.4.1. Genomic
7.4.2. Proteomic
7.4.3. Metabolomic
7.4.4. Imaging
7.4.5. Others
Chapter 8. Global Neurological Biomarkers Market, by End-use
8.1. Market Snapshot
8.2. Global Neurological Biomarkers Market by End-use, Performance – Potential Analysis
8.3. Global Neurological Biomarkers Market Estimates & Forecasts by End-use 2018-2027 (USD Billion)
8.4. Neurological Biomarkers Market, Sub Segment Analysis
8.4.1. Hospital & Hospital Laboratories
8.4.2. Independent Clinical Diagnostic Centers
8.4.3. Research Organizations and Others
Chapter 9. Global Neurological Biomarkers Market, Regional Analysis
9.1. Neurological Biomarkers Market, Regional Market Snapshot
9.2. North America Neurological Biomarkers Market
9.2.1. U.S. Neurological Biomarkers Market
9.2.1.1. Application breakdown estimates & forecasts, 2018-2027
9.2.1.2. Type breakdown estimates & forecasts, 2018-2027
9.2.1.3. End-use breakdown estimates & forecasts, 2018-2027
9.2.2. Canada Neurological Biomarkers Market
9.3. Europe Neurological Biomarkers Market Snapshot
9.3.1. U.K. Neurological Biomarkers Market
9.3.2. Germany Neurological Biomarkers Market
9.3.3. France Neurological Biomarkers Market
9.3.4. Spain Neurological Biomarkers Market
9.3.5. Italy Neurological Biomarkers Market
9.3.6. Rest of Europe Neurological Biomarkers Market
9.4. Asia-Pacific Neurological Biomarkers Market Snapshot
9.4.1. China Neurological Biomarkers Market
9.4.2. India Neurological Biomarkers Market
9.4.3. Japan Neurological Biomarkers Market
9.4.4. Australia Neurological Biomarkers Market
9.4.5. South Korea Neurological Biomarkers Market
9.4.6. Rest of Asia Pacific Neurological Biomarkers Market
9.5. Latin America Neurological Biomarkers Market Snapshot
9.5.1. Brazil Neurological Biomarkers Market
9.5.2. Mexico Neurological Biomarkers Market
9.6. Rest of The World Neurological Biomarkers Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Abbott Laboratories
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Bio-Rad Laboratories, Inc
10.2.3. Thermo Fisher Scientific Inc
10.2.4. F. Hoffman-La Roche Ltd
10.2.5. Johnson and Johnson services inc
10.2.6. Rules Based Medicine – a Q2 Solutions Company
10.2.7. Quanterix
10.2.8. ADx Neurosciences
10.2.9. Banyan Biomarker, Inc.
10.2.10. Abcam Plc
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

The study of the market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geographies to provide a better regional outlook. In the report, country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. Our analysts contact company executives, managers, key opinion leaders, and industry experts. This enables our analyst to derive the closest possible figures without any major deviations in the actual number.

Primary Research Sources:

  • Interview conducted with raw material suppliers & manufacturers.
  • Interview conducted with manufacturers, suppliers & distributors, researchers, & representatives of regulatory bodies.
  • Interview conducted with market players, industry experts, & independent consultants.
  • Secondary Research Sources:
  • Purchased Database: D&B Hoovers, Bloomberg, Inc., Business Information Industry Association, NAICS Association.
  • Internal Database: White papers, Certified Publications, Articles by Recognized Authors and Regulatory Bodies.
  • Government Databases: Food and Agriculture Organization (FAO), European Industrial Hemp Association (EIHA), World Health Organization (WHO), Food and Drug Administration (FDA), International Telecommunication Union (ITU), United States Department of Agriculture (USDA), International organization of Motor Vehicle Manufacturers (OICA).

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now